Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting, 23275 [2013-09135]

Download as PDF Federal Register / Vol. 78, No. 75 / Thursday, April 18, 2013 / Notices Agency will remove OXYCONTIN (oxycodone hydrochloride) extendedrelease tablets (10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg) approved under NDA 20–553 from the list of drug products published in the Orange Book. FDA will not accept or approve ANDAs that refer to these drug products. sroberts on DSK5SPTVN1PROD with NOTICES IV. References The following references have been placed on display in the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, and may be seen by interested persons between 9 a.m. and 4 p.m., Monday through Friday, and are available electronically at http:// www.regulations.gov. (FDA has verified the Web site addresses in this reference section, but FDA is not responsible for any subsequent changes to the Web sites after this document publishes in the Federal Register.) 1. National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), ‘‘Policy Impact: Prescription Painkiller Overdoses’’ (www.cdc.gov/ HomeandRecreationalSafety/pdf/ PolicyImpact-Prescription PainkillerOD.pdf). 2. CDC, ‘‘Vital Signs: Overdoses of Prescription Opioid Pain Relievers— United States, 1999–2008,’’ Morbidity and Mortality Weekly Report, vol. 60, No. 43, pp. 1487–1492, 2011 (www.cdc.gov/mmwr/pdf/wk/ mm6043.pdf). 3. National Center for Injury Prevention and Control, CDC, ‘‘Unintentional Drug Poisoning in the United States’’ (www.cdc.gov/HomeandRecreational Safety/pdf/poison-issue-brief.pdf). 4. Jones, C.M., K.A. Mack, and L.J. Paulozzi, ‘‘Pharmaceutical Overdose Deaths, United States, 2010,’’ Journal of the American Medical Association, vol. 309, pp. 657–659, 2013. 5. FDA, ‘‘FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics’’ (http:// www.fda.gov/downloads/drugs/ drugsafety/informationbydrugclass/ ucm277916.pdf). 6. FDA, ‘‘Draft Guidance for Industry: AbuseDeterrent Opioids—Evaluation and Labeling,’’ (www.fda.gov/downloads/ Drugs/GuidanceCompliance RegulatoryInformation/Guidances/ UCM334743.pdf). 7. Katz, N., R.C. Dart, E. Bailey, et al., ‘‘Tampering With Prescription Opioids: Nature and Extent of the Problem, Health Consequences, and Solutions,’’ The American Journal of Drug and Alcohol Abuse, vol. 37, pp. 205–217, 2011. 8. Silva, K., S.M. Schrager, A. Kecojevic, et al., ‘‘Factors Associated With History of Non-Fatal Overdose Among Young Nonmedical Users of Prescription VerDate Mar<15>2010 18:54 Apr 17, 2013 Jkt 229001 Drugs,’’ Drug and Alcohol Dependence, vol. 128, pp. 104–110, 2013. 9. Degenhardt, L., C. Bucello, B. Mathers, et al., ‘‘Mortality Among Regular or Dependent Users of Heroin and Other Opioids: A Systematic Review and MetaAnalysis of Cohort Studies,’’ Addiction, vol. 106, pp. 32–51, 2011. 10. CDC, ‘‘Integrated Prevention Services for HIV Infection, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis for Persons Who Use Drugs Illicitly: Summary Guidance From the CDC and the U.S. Department of Health and Human Services,’’ Morbidity and Mortality Weekly Report, vol. 61, pp. 1– 40, 2012. 11. Alexander, D., K. Alexander, and J. Valentino, ‘‘Intranasal HydrocodoneAcetaminophen Abuse-Induced Necrosis of the Nasal Cavity and Pharynx,’’ The Laryngoscope, vol. 122, pp. 2378–2381, 2012. Dated: April 12, 2013. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2013–09092 Filed 4–16–13; 4:15 pm] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Interdisciplinary, Community-Based Linkages (ACICBL). Dates and Times: April 22, 2013, 8:30 a.m.–5:00 p.m., April 23, 2013, 9:00 a.m.–5:00 p.m. Place: Health Resources and Services Administration, U.S. Department of Health and Human Services, 5600 Fishers Lane, Rockville, Maryland 20852, Room 18–57. Status: The meeting will be open to the public. Purpose: The members of the ACICBL will begin discussions to develop the legislatively mandated 13th Annual Report to the Secretary of Health and Human Services and Congress. The Committee members will focus on the working topic: Optimizing the Interprofessional Team Member’s Contributions to Population Health. The Committee has invited Dr. John Gilbert, former Principal and Professor Emeritus at the University of British Columbia, Canada; Ms. Rachel Watman, Senior Program Officer, The John A. Hartford PO 00000 Frm 00072 Fmt 4703 Sfmt 9990 23275 Foundation; Dr. John Bulger, Chief Quality Officer, Geisinger Health System; Dr. Paul McGann, Deputy Chief Medical Officer for Innovation Grants, Centers for Medicare & Medicaid Services; Dr. Thomas Edes, Director of Home and Community-Based Care, U.S. Department of Veterans Affairs; and Dr. Alex Camacho, Deputy Director, Office of Performance Measurement, Health Resources and Services Administration. The meeting will afford committee members with the opportunity to identify and discuss population health; interprofessional education, care and competencies; and best practices and the like in an effort to formulate appropriate recommendations for the Secretary and the Congress. Agenda: The ACICBL agenda includes an overview of the Committee’s general business activities, presentations by and dialogue with experts, and discussion sessions specifically for the development of recommendations to be addressed in the 13th Annual ACICBL Report. The agenda will be available 2 days prior to the meeting on the HRSA Web site (http://www.hrsa.gov/ advisorycommittees/bhpradvisory/ acicbl/acicbl.html). Agenda items are subject to change as priorities dictate. Members of the public and interested parties may request to provide comments or register to attend the meeting by emailing their first name, last name, and full email address to BHPRAdvisoryCommittee@hrsa.gov or by contacting Ms. Crystal Straughn at 301–443–3594. Registration is first come, first served as space is limited. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACICBL should contact Dr. Joan Weiss, Designated Federal Official within the Bureau of Health Professions, Health Resources and Services Administration, in one of three ways: (1) Send a request to the following address: Dr. Joan Weiss, Designated Federal Official, Bureau of Health Professions, Health Resources and Services Administration, Parklawn Building, Room 9C–05, 5600 Fishers Lane, Rockville, Maryland 20857; (2) call (301) 443–6950; or (3) send an email to jweiss@hrsa.gov. Dated: April 11, 2013. Bahar Niakan, Director, Division of Policy and Information Coordination. [FR Doc. 2013–09135 Filed 4–17–13; 8:45 am] BILLING CODE 4165–15–P E:\FR\FM\18APN1.SGM 18APN1

Agencies

[Federal Register Volume 78, Number 75 (Thursday, April 18, 2013)]
[Notices]
[Page 23275]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09135]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Service Administration


Advisory Committee on Interdisciplinary, Community-Based 
Linkages; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Committee on Interdisciplinary, Community-Based 
Linkages (ACICBL).
    Dates and Times: April 22, 2013, 8:30 a.m.-5:00 p.m., April 23, 
2013, 9:00 a.m.-5:00 p.m.
    Place: Health Resources and Services Administration, U.S. 
Department of Health and Human Services, 5600 Fishers Lane, Rockville, 
Maryland 20852, Room 18-57.
    Status: The meeting will be open to the public.
    Purpose: The members of the ACICBL will begin discussions to 
develop the legislatively mandated 13th Annual Report to the Secretary 
of Health and Human Services and Congress. The Committee members will 
focus on the working topic: Optimizing the Interprofessional Team 
Member's Contributions to Population Health. The Committee has invited 
Dr. John Gilbert, former Principal and Professor Emeritus at the 
University of British Columbia, Canada; Ms. Rachel Watman, Senior 
Program Officer, The John A. Hartford Foundation; Dr. John Bulger, 
Chief Quality Officer, Geisinger Health System; Dr. Paul McGann, Deputy 
Chief Medical Officer for Innovation Grants, Centers for Medicare & 
Medicaid Services; Dr. Thomas Edes, Director of Home and Community-
Based Care, U.S. Department of Veterans Affairs; and Dr. Alex Camacho, 
Deputy Director, Office of Performance Measurement, Health Resources 
and Services Administration. The meeting will afford committee members 
with the opportunity to identify and discuss population health; 
interprofessional education, care and competencies; and best practices 
and the like in an effort to formulate appropriate recommendations for 
the Secretary and the Congress.
    Agenda: The ACICBL agenda includes an overview of the Committee's 
general business activities, presentations by and dialogue with 
experts, and discussion sessions specifically for the development of 
recommendations to be addressed in the 13th Annual ACICBL Report. The 
agenda will be available 2 days prior to the meeting on the HRSA Web 
site (http://www.hrsa.gov/advisorycommittees/bhpradvisory/acicbl/acicbl.html). Agenda items are subject to change as priorities dictate.

SUPPLEMENTARY INFORMATION: Members of the public and interested parties 
may request to provide comments or register to attend the meeting by 
emailing their first name, last name, and full email address to 
BHPRAdvisoryCommittee@hrsa.gov or by contacting Ms. Crystal Straughn at 
301-443-3594. Registration is first come, first served as space is 
limited.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the ACICBL should contact Dr. Joan Weiss, Designated Federal 
Official within the Bureau of Health Professions, Health Resources and 
Services Administration, in one of three ways: (1) Send a request to 
the following address: Dr. Joan Weiss, Designated Federal Official, 
Bureau of Health Professions, Health Resources and Services 
Administration, Parklawn Building, Room 9C-05, 5600 Fishers Lane, 
Rockville, Maryland 20857; (2) call (301) 443-6950; or (3) send an 
email to jweiss@hrsa.gov.

    Dated: April 11, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-09135 Filed 4-17-13; 8:45 am]
BILLING CODE 4165-15-P